Canadian ophthalmological society evidence-based clinical practice guidelines for the periodic eye examination in adults in Canada;Guide de pratique clinique factuelle de la Société canadienne d'ophtalmologie pour l'examen oculaire périodique chez les adultes au Canada

Canadian Journal of Ophthalmology

Volumn 42, Issue 1, 2007, Pages

  Delpero, Walter ^a   Beiko, George ^b   Casey, Ronald ^c   Ells, Anna ^d   Kertes, Peter ^e   Molgat, Yvonne ^f   Nagy, Tom ^g  

^a Comprehensive Ophthalmology/Catharact Surgery ^*  (Canada)

^b Comprehensive Ophthalmology/Catharact/Refractive ^*  (Canada)

^c Glaucoma   (Canada)

^d Pediatric/Retina   (Canada)

^e Retina   (Canada)

^f Oculoplastics   (Canada)

^g Comprehensive Ophthalmology ^*  (Canada)

Author keywords

Clinical practice guidelines; Comprehensive eye examination; Oculovisual assessment; Oculovisual examination; Periodic eye examination; Vision screening

Indexed keywords

HYDROXYCHLOROQUINE; TAMOXIFEN;

ARTICLE; CANADA; CATARACT; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DIABETIC RETINOPATHY; EVIDENCE BASED PRACTICE; EYE CARE; GLAUCOMA; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HUMAN; MEDICAL SOCIETY; OPHTHALMOSCOPY; PATIENT CARE; PERIODIC MEDICAL EXAMINATION; PRACTICE GUIDELINE; PREVALENCE; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 33947171075     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1139/I06-126e     Document Type: Article

References (49)

1. Kane RL. Creating practice guidelines: the dangers of over-reliance on expert judgement. J Law Med Ethics 1995;23:62-4.
2. Schwartz PJ, Breithardt G, Howard AJ, Julian DG, Rehnqvist Ahlberg N. The legal implications of medical guidelines - a Task Force of the European Society of Cardiology. Eur Heart J 1999;20:1152-7.
3. College of Physicians and Surgeons of Ontario. Position Statement. The College's expectations on the use of clinical practice guidelines. Dialogue 2005;Nov/Dec:12-13.
4. Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 2002;287:612-7.
5. Picone G, Brown D, Sloan F. Do routine eye examinations improve vision? Int J Health Care Finance Economics 2004;4:43-63.
6. The AGREE Collaboration. Appraisal of Guidelines Research and Evaluation (AGREE) instrument. 2001. Available: www.agreecollaboration.org/instrument (accessed 2006 Dec 13).
7. U.S. Preventative Services Task Force. Screening for Visual Impairment in Children Younger than Age 5 Years: Recommendation Statement. May 2004. Agency for Healthcare Research and Quality, Rockville, MD. Available: http://www.ahrq.gov/clinic/3rduspstf/visionscr/vischrs.htm (accessed 2006 Dec 13).
8. Community Paediatrics Committee. Canadian Paediatric Society. Vision screening in infants, children and youth. Paed Child Health 1998;3:261-2. Reaffirmed 2005. Available: https://www.cps.ca/English/statements/CP/cp98-01. htm (accessed 2006 Dec 13).
9. Taylor HR, Vu HT, McCarty CA, Keeffe JE. The need for routine eye examinations. Invest Ophthalmol Vis Sci 2004;45: 239-42.
10. Foran S, Mitchell P, Wang JJ. Five-year change in visual acuity and incidence of visual impairment: the Blue Mountains Eye Study. Ophthalmology 2003;110:41-50.
11. Dimitrov PN, Mukesh BN, McCarty CA, Taylor HR. Five-year incidence of bilateral cause-specific visual impairment in the Melbourne Visual Impairment project. Invest Ophthalmol Vis Sci 2003;44:5075-81.
12. Klein R, Klein BEK, Lee KE. Changes in visual acuity in a population. The Beaver Eye Dam Study. Ophthalmology 1996;103:1169-78.
13. Coffield AB, Maciosek MV, McGinnis JM, Harris JR, Caldwell MB, Teutsh SM, et al. Priorities among recommended clinical preventive services. Am J Prev Med 2001;21: 10-19.
14. Klein BEK, Moss SE, Klein R, Cruickshanks KJ. Associations of visual function with physical outcomes and limitations 5 years later in an older population: the Beaver Dam Study. Ophthalmology 2003;110:644-50.
15. Patterson C. Screening for visual impairment in the elderly. In: Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventative Health Care. Ottawa: Health Canada; 1994:932-42.
16. Smeeth L, Iliffe S. Effectiveness of screening older people for impaired vision in a community setting: systematic review of evidence from randomised controlled trials. BMJ 1998;316:660-3.
17. Vitale S, Cotch MF, Sperduto RD. Prevalence of visual impairment in the United States. JAMA 2006;295:2158-63.
18. Liou HL, McCarty CA, Jin CL, Taylor HR. Prevalence and predictors of undercorrected refractive errors in the Victorian population. Am J Ophthalmol 1999;127:590-6.
19. Macias EP, Lee DA, Oelrich FO. Refractive errors and visual acuity impairment among self-selected Hispanic, white and black adults examined by the UCLA Mobile Eye Clinic. J Am Optom Assoc 1999;70:724-34.
20. Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology 1996;103:357-64.
21. Weih LM, VanNewkirk MR, McCarty CA, Taylor HR. Age-specific causes of bilateral visual impairment. Arch Ophthlamol 2000;108:264-9.
22. Klaver CC, Wolfs RC, Vingerling Jr, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 1998;116:653-8.
23. Cedrone C, Culasso F, Cesareo M, Nucci See, Palma S, Mancino R, et al. Incidence of blindness and low vision in a sample population. The Priverno Eye Study, Italy. Ophthalmology 2003;110:584-8.
24. Kinge B, Midelfart A. Refractive changes among Norwegian university students: a 3-year longitudinal study. Acta Ophthalmol Scand 1999;77:302-5.
25. Lee KE, Klein BEK, Klein R, Wong TY. Changes in refraction over 10 years in an adult population: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 2002;43:2566-71.
26. Ariyasu RG, Lee PP, Linton KP, LaBree LD, Azen SP, Siu AL. Sensitivity, specificity, and predictive values of screening tests for eye conditions in a clinic-based population. Ophthalmology 1996;103:1751-60.
27. Schneck ME, Haegerstrom-Portnoy G, Lott LA, Brabyn JA, Gildengorin G. Low contrast vision function predicts subsequent acuity loss in an aged population: the SKI study. Vision Res 2004;44:2317-25.
28. Batchelder TJ, Fireman B, Friedman GD, Mattas BR, Wong IG, Barrick ME, et al. The value of routine dilated pupil screening examination. Arch Ophthalmol 1997;115:1179-84.
29. Aylward GW. Screening for retinal detachment. J Med Screen 2001;8:116-8.
30. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2003;27(suppl2):S76-S80.
31. Rahmani B, Tielsch J, Katz J, Gottsch J, Quigley H, Javitt J, et al. The cause-specific prevalence of visual impairment in an urban population: The Baltimore Eye Survey. Ophthalmology 1996;103:1721-4.
32. Younis N, Broadbent DM, Harding SP, Vora JP. Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme. Diabet Med 2003;20:758-65.
33. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1989;107:237-43.
34. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-6.
35. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol 1989;107:244-9.
36. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102:527-32.
37. Klein BEK, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care 1990;13:34-40.
38. Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the Diabetes Control and Complications Trial. Diabetes Care 2000;23:1084-91.
39. Sponsel WE, Shoemaker J, Trigo Y, Mensch J, Rugwani R, Garrett B. Frequency of sustained glaucomatous-type visual field loss and associated optic nerve cupping in Beaver Dam, Wisconsin. Clin Experiment Ophthalmol 2001;29:352-8.
40. Wensor MD, McCarty CA, Stanislavsky YL, Livingstone PM, Taylor HR. The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology 1998;105:733-9.
41. Salmon JE Screening for chronic glaucoma. J Med Screen 2006;13:1-3.
42. Congdon N, O'Colmain B, Klaver CC, Klein Are, Munoz B, Friedman DS, et al, for the Eye Disease Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004;122: 477-85.
43. Tuck MW. The age distribution of primary open angle glaucoma. Ophthalmic Epidemiol 1998;5:173-83.
44. Age-Related Eye Disease Study Research Group. A randomized placebo-controlled trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: Age-Related Eye Disease Study report no. 8. Arch Ophthalmol 2001;119: 1417-36.
45. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 2000;107:2224-32.
46. VanNewkirk MR, Nanjan MB, Wang JJ, Mitchell P, Taylor HR, McCarty CA. The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology 2000;107:1593-600.
47. VanNewkirk MR, Weih L, McCarty CA, et al. Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the Visual Impairment Project. Ophthalmology 2001;108:960-7.
48. Van den Born BJ, Hulsman CA, Hoekstra JB, Schlingemann RO, van Montfrans GA. Value of routine funduscopy in patients with hypertension: systematic review. BMJ 2005;331:73.
49. Ferraro JG, Mazzoni LL, Keeffe JE, Vu HT, Constantinou M, Tayor HR. Evaluation of an eye health program: the vision initiative. Ophthalmic Epidemiol 2006;13:127-35.